KIDRON NADAV 13D and 13G filings for Oramed Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-03-22 9:30 pm Purchase | 2024-03-06 | 13D | Oramed Pharmaceuticals Inc. ORMP | KIDRON NADAV | 2,343,919 5.700% | 1,000,473 (+74.47%) | Filing |
| 2021-09-02 4:49 pm Sale | 2021-08-19 | 13D | Oramed Pharmaceuticals Inc. ORMP | KIDRON NADAV | 1,343,446 4.100% | -1,288,614 (-48.96%) | Filing |